Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-20

FDA Approved: APRETUDE — Original Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved APRETUDE (cabotegravir) for HIV pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV-1 infection in adults and in adolescents weighi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APRETUDE (CABOTEGRAVIR)

Snippet

ORIG AP for APRETUDE (CABOTEGRAVIR)